Status:
ENROLLING_BY_INVITATION
A Randomized Controlled Trial of Menopausal Tool/App for Women
Lead Sponsor:
Mayo Clinic
Conditions:
Menopausal Symptoms
Menopause Symptom Management
Eligibility:
All Genders
24-80 years
Phase:
NA
Brief Summary
The purpose of this study is about assessing the utilization of a mobile phone application (app), designed to improve the menopause experience of midlife women experiencing related symptoms and its as...
Eligibility Criteria
Inclusion
- For Patient Enrollment:
- Women between the ages of 45 and 55
- English speaking (app only available in English)
- Able to provide informed consent
- Experiencing menopause symptoms, which will be assessed by a Menopause Rating Scale (MRS) survey score of ≥ 5
- Has an upcoming Mayo Clinic primary care appointment within 3 weeks of the enrollment and the MRS survey
Exclusion
- Lack of willingness to engage with app
- Inability to provide informed consent
Key Trial Info
Start Date :
May 7 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 15 2027
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT06919887
Start Date
May 7 2025
End Date
December 15 2027
Last Update
June 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905